Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4849 |  XCUR Exicure, Inc. - Common Stock | 1.14 USD | -0.87% | -11.63% | -33.72% | -81.00% | 7.46 M USD | ||
| 4852 |  ALZN Alzamend Neuro, Inc. - Common Stock | 1.46 USD | -6.41% | -5.81% | +8.15% | -40.41% | 7.00 M USD | ||
| 4856 |  CURX Curanex Pharmaceuticals Inc - Common Stock | 4.58 USD | -2.76% | +1981.82% | +2190.00% | +20.53% | 7.18 M USD | ||
| 4860 |  ENSC Ensysce Biosciences, Inc. - Common Stock | 0.36 USD | -2.70% | -7.69% | +38.46% | -5.26% | 7.00 M USD | ||
| 4862 |  BOLT Bolt Biotherapeutics, Inc. - Common Stock | 3.78 USD | +3.00% | +15.24% | -5.97% | -26.46% | 7.28 M USD | ||
| 4866 |  LIMN Liminatus Pharma, Inc. - Class A Common Stock | 4.88 USD | -5.24% | +3385.71% | +4336.36% | +48.78% | 6.55 M USD | ||
| 4873 |  IMRN Immuron Limited - American Depositary Shares | 1.14 USD | 0.00% | +2.70% | +1.79% | -36.67% | 6.67 M USD | ||
| 4880 |  XTLB XTL Biopharmaceuticals Ltd - American Depositary Shares | 2.76 USD | 0.00% | +4.15% | -3.50% | +206.67% | 6.53 M USD | ||
| 4886 |  ENVB Enveric Biosciences, Inc. - Common Stock | 1.40 USD | -2.10% | -3.45% | +6.06% | -43.09% | 6.27 M USD | ||
| 4887 |  NCNA NuCana plc - American Depositary Shares | 1.49 USD | -1.97% | -2.61% | +9.56% | -30.70% | 6.20 M USD | ||
| 4894 |  ADXN Addex Therapeutics Ltd - American Depositary Shares | 4.50 USD | -8.91% | -23.34% | -22.41% | -43.04% | 5.54 M USD | ||
| 4900 |  CDIO Cardio Diagnostics Holdings Inc. - Common stock | 1.93 USD | -4.93% | -5.39% | +25.32% | -26.34% | 5.71 M USD | ||
| 4910 |  PCSA Processa Pharmaceuticals, Inc. - Common Stock | 2.07 USD | -0.48% | -8.81% | -23.05% | -6.76% | 5.78 M USD | ||
| 4914 |  BGMS Bio Green Med Solution, Inc. - Common Stock | 0.88 USD | +1.15% | -4.35% | -2.22% | -85.33% | 5.83 M USD | ||
| 4915 |  CVKD Cadrenal Therapeutics, Inc. - Common Stock | 1.64 USD | +1.86% | -7.34% | -23.36% | -70.29% | 5.85 M USD | ||
| 4918 |  DRMA Dermata Therapeutics, Inc. - Common Stock | 1.43 USD | +0.70% | +2.88% | +11.72% | 0.00% | 5.75 M USD | ||
| 4921 |  PMCB PharmaCyte Biotech, Inc. - Common Stock | 0.53 USD | 0.00% | -3.64% | -11.67% | -44.21% | 5.69 M USD | ||
| 4924 |  BRTX BioRestorative Therapies, Inc. - Common Stock | 0.23 USD | +4.55% | 0.00% | -20.69% | -84.97% | 5.86 M USD | ||
| 4929 |  PULM Pulmatrix, Inc. - Common Stock | 1.43 USD | -4.67% | -5.30% | -12.80% | -70.70% | 5.22 M USD | ||
| 4932 |  BCAB BioAtla, Inc. - Common Stock | 3.41 USD | +5.25% | +10.00% | +2.10% | +847.22% | 5.68 M USD |
Noticias Biotechnology Stocks
Deutsche Bank rebaja argenx a Mantener por valoración
¿Por qué cae hoy la acción de Monte Rosa Therapeutics?
Las acciones de Biomea Fusion se disparan tras completar el ensayo sobre diabetes
Las acciones de Monte Rosa caen al inicio de un estudio de fase 2 contra el cáncer de próstata
Las acciones de Crinetics Pharmaceuticals alcanzan máximos históricos en 84,8 dólares
H.C. Wainwright reitera su calificación de Biomea Fusion tras inscripción en ensayo
La FDA amplía la revisión de deramiocel de Capricor hasta el 22 de noviembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |